Why Wall Street Is Growing More Cautious on Biohaven (BHVN)

With EPS growth for the next five years forecasted at 31.63%, Biohaven Ltd. (NYSE:BHVN) is among the 12 Best Quality Stocks to Buy and Hold for the Next Decade.

On June 29, BofA downgraded Biohaven Ltd. (NYSE:BHVN) to Underperform from Neutral and lowered its price target to $11 from $12, citing a more cautious view of the company’s near-term risk-reward profile ahead of an important clinical catalyst. The firm pointed to the upcoming Phase 3 data for Biohaven’s Kv7 epilepsy program, expected in the second half of the year, as a pivotal event for the stock. BofA noted that Biohaven trails a competing program from Xenon Pharmaceuticals by at least two years and believes consensus expectations for approximately $1 billion in peak sales could face downside risk unless the company demonstrates meaningful clinical differentiation.

Earlier, on June 26, Deutsche Bank raised its price target on Biohaven Ltd. (NYSE:BHVN) to $20 from $15 while maintaining a Buy rating. The firm highlighted Biohaven’s troriluzole program for spinocerebellar ataxia as a potentially significant value driver, suggesting that the therapy could benefit from the U.S. Food and Drug Administration’s recent willingness to reconsider and reverse previous regulatory decisions in certain neurological diseases. Deutsche Bank believes the evolving regulatory environment may improve the prospects for Biohaven’s pipeline and create additional upside if clinical data remain favorable.

Biohaven Ltd. (NYSE:BHVN) is a clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut, and was founded in 2022 following the spin-off of the non-CGRP assets from the legacy Biohaven organization established in 2013. The company focuses on discovering and developing innovative therapies targeting neurological and neuropsychiatric disorders, immunological diseases, and oncology, with a broad pipeline of late- and early-stage development programs.

READ NEXT: 7 Best Fusion Energy Development Stocks to Buy and 7 Best Battery Technology Stocks to Buy for Grid Storage.

Disclosure: None.  Follow Insider Monkey on Google News.